Skip to main content
. 2021 Jun 8;13:617–629. doi: 10.2147/HIV.S301355

Table 4.

Clinical and Immunological Factors with INH Status and Cumulative TB Incidence in HIV Infected Individuals in Northwest Ethiopia, September 11, 2008 to March, 2015, N = 391

Clinical Variables INH Completed Never on INH
TB (%) Total TB (%) Total
WHO stage
Stage I 1(1.6) 63.0 2(3.4) 58.0
Stage II 0(0.0) 45.0 2(4.1) 47.0
Stage III 1(1.2) 74.0 23(29.5) 78.0
Stage IV 0(0.0) 5.00 9(69.2) 13.0
Previous TB rx
Yes 0(0.0) 23.0 6(27.3) 22.0
No 2(1.2) 170 30(17.0) 176
B. functional sta.
Working 2(1.3) 155 21(13.4) 157
Ambulatory & Bed. 0(0.0) 38.0 15(36.6) 41.0
Baseline BMI
<18.5 kg/m2 1(1.6) 64.0 22(25.3) 87.0
≥18.5 kg/m2 1(0.8) 129 14(12.6) 111
Baseline Hgb.
<10 mg/dl 0(0.0) 5.00 1(11.1) 9.00
10–12 mg/dl 0(0.0) 26.0 21(25.6) 53.0
>12 mg/dl 2(1.2) 162 24(16.4) 146
Baseline CD4
≤100 cells/μL 0(0.0) 35.0 14(30.4) 56.0
101–200 cells/μL 0(0.0) 49.0 6(10.5) 57.0
201–350 cells/μL 0(0.0) 50.0 11(23.4) 47.0
>350 cells/μL 2(3.4) 59.0 5(10.4) 48.0
CD4 at ART in.
≤100 cells/μL 0(0.0) 35.0 3(8.1) 37.0
101–200 cells/μL 0(0.0) 68.0 1(1.6) 61.0
201–350 cells/μL 0(0.0) 51.0 2(5.1) 39.0
>350 cells/μL 0(0.0) 18.0 2(7.4) 27.0
ART status
On ART 0(0.0) 172 8(4.9) 164
On Pre-ART 2(9.5) 21.0 28(82.4) 34.0
Duration of ART
< 2 years 0(0.0) 27.0 6(18.8) 32.0
2–3 years 0(0.0) 18.0 1(0.8) 118
>3 years 0(0.0) 127 1(7.1) 14.0
Past OIs other than TB
Yes 0(0.0) 80.0 19(19.8) 96.0
No 2(1.8) 113 17(16.7) 102
CPT initiation
Yes 0(0.0) 167 30(17.8) 169
No 2(7.7) 25.0 6(20.7) 29.0

Abbreviations: TB rx hx, tuberculosis treatment history; sta, status; BMI, body mass index; Hgb, hemoglobin; CPT, cotrimoxazole preventive therapy; OIs, opportunistic infections; μL, micro litters; mg/dl, milligram per deciliter.